-- Days : -- HRS : -- MIN : -- SEC

Register Now →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael Kolodziej, MD, FACP

Articles by Michael Kolodziej, MD, FACP

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL

ByKathryn Fitch, RN, MEd,Michael Kolodziej, MD, FACP

March 10th 2022

Management of Biochemically Recurrent Prostate Cancer Following Local Therapy

ByMichael Kolodziej, MD, FACP

January 8th 2015

Latest Updated Articles

Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
March 10th 2022
Management of Biochemically Recurrent Prostate Cancer Following Local Therapy
January 8th 2015

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

Predicting GLP-1 Discontinuation From Pharmacy Claims

High-Dose Vitamin D3 Fails to Improve PFS in Phase 3 Metastatic CRC Trial

Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL